It is noteworthy, that EVOO-based HFD significantly decreased fasting glycemia, insulinemia and insulin resistance at the end of the interventional study (Fig. 2), as well as significantly lowered insulin release after a glucose challenge and significantly improved KITT (Fig. 3). This evidence concerns the gene INS and Insulin resistance.